LakeShore Biopharma Co., Ltd (LSB)
LSB Stock Price Chart
Explore LakeShore Biopharma Co., Ltd interactive price chart. Choose custom timeframes to analyze LSB price movements and trends.
LSB Company Profile
Discover essential business fundamentals and corporate details for LakeShore Biopharma Co., Ltd (LSB) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
5 Aug 2021
Employees
758.00
Website
https://www.ysbiopharm.comCEO
Wang Xu
Description
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
LSB Financial Timeline
Browse a chronological timeline of LakeShore Biopharma Co., Ltd corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 20 Apr 2026
Upcoming earnings on 19 Jan 2026
Upcoming earnings on 30 Oct 2025
Earnings released on 31 Jul 2025
Earnings released on 18 Apr 2025
EPS came in at -$1.20 falling short of the estimated -$0.60 by -100.00%.
Earnings released on 27 Jan 2025
EPS came in at -$1.60 falling short of the estimated -$0.80 by -100.00%.
Earnings released on 19 Dec 2024
Stock split effective on 4 Oct 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 24 Sept 2024
EPS came in at -$1.34 falling short of the estimated -$0.58 by -131.03%.
Earnings released on 19 Apr 2024
EPS came in at -$0.12 falling short of the estimated -$0.09 by -33.33%, while revenue for the quarter reached $135.53M , beating expectations by +574.03%.
Earnings released on 30 Dec 2023
EPS came in at -$0.86 , while revenue for the quarter reached $168.71M .
Earnings released on 30 Sept 2023
EPS came in at -$1.13 , while revenue for the quarter reached $96.82M .
Earnings released on 30 Jun 2023
EPS came in at -$0.75 , while revenue for the quarter reached $176.27M .
Earnings released on 31 Mar 2023
EPS came in at -$17.98 , while revenue for the quarter reached $106.12M .
Earnings released on 31 Dec 2022
EPS came in at -$0.85 , while revenue for the quarter reached $180.46M .
Earnings released on 30 Sept 2022
EPS came in at $0.14 , while revenue for the quarter reached $194.79M .
Earnings released on 29 Jun 2022
EPS came in at $0.45 .
Earnings released on 30 Mar 2022
EPS came in at $1.76 .
Earnings released on 30 Dec 2021
EPS came in at $0.67 .
Earnings released on 29 Sept 2021
EPS came in at $0.23 .
Earnings released on 29 Jun 2021
EPS came in at -$1.05 .
LSB Stock Performance
Access detailed LSB performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.